The steroid hormone ADIOL promotes learning by reducing neural kynurenic acid levels

Genes Dev. 2023 Dec 26;37(21-24):998-1016. doi: 10.1101/gad.350745.123.

Abstract

Reductions in brain kynurenic acid levels, a neuroinhibitory metabolite, improve cognitive function in diverse organisms. Thus, modulation of kynurenic acid levels is thought to have therapeutic potential in a range of brain disorders. Here we report that the steroid 5-androstene 3β, 17β-diol (ADIOL) reduces kynurenic acid levels and promotes associative learning in Caenorhabditis elegans We identify the molecular mechanisms through which ADIOL links peripheral metabolic pathways to neural mechanisms of learning capacity. Moreover, we show that in aged animals, which normally experience rapid cognitive decline, ADIOL improves learning capacity. The molecular mechanisms that underlie the biosynthesis of ADIOL as well as those through which it promotes kynurenic acid reduction are conserved in mammals. Thus, rather than a minor intermediate in the production of sex steroids, ADIOL is an endogenous hormone that potently regulates learning capacity by causing reductions in neural kynurenic acid levels.

Keywords: 5-androstenediol; estrogen receptor β; kynurenic acid; kynurenine pathway; nuclear hormone receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Hormones
  • Kynurenic Acid* / pharmacology
  • Mammals
  • Steroids*

Substances

  • Kynurenic Acid
  • Steroids
  • Hormones